Á¦2Â÷ ´ëÇѹé¹ÝÁõ»ö¼ÒÇÐȸ ½ÉÆ÷Áö¾ö : 2022-06-12±³À°ÀÏÀÚ : 2022-06-12
±³À°Àå¼Ò : »ïÁ¤È£ÅÚ ½Å°ü2Ãþ Á¦¶ó´½È¦ ¿Ü 1°³È¦ (1Ãþ ·ÎÁ¸®È¦)
±³À°ÁÖÁ¦ :
Á¦2Â÷ ´ëÇѹé¹ÝÁõ»ö¼ÒÇÐȸ ½ÉÆ÷Áö¾öÁÖÃÖ±â°ü : ´ëÇÑÇǺΰúÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѹé¹ÝÁõ»ö¼ÒÇÐȸ
´ã´çÀÚ : ¿À»óÈ£ ±³¼ö
¿¬¶ôó : 02-2228-2080
À̸ÞÀÏ :
ODDUNG9@yuhs.ac ±³À°Á¾·ù : ÇǺΰú
Âü¼®¿¹»óÀοø : 150¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 6 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 500,000¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 06-12 Á¦¶ó´½È¦ 09:10~09:25 Basic mechanisms regulating melanogenesis: Focus on PIH ±èÁ¤Àº(ÇѾçÀÇ´ë)
±³À°½Ã°£ 06-12 Á¦¶ó´½È¦ 09:25~09:40 Treatment of PIH in the real field: A to Z Á¤º¸¿µ(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 06-12 Á¦¶ó´½È¦ 09:40~09:55 Prevention of PIH: Tips for minimizing PIH after procedures? ±èÀçÈ«(¿¬¼¼Á¶ÀºÇǺΰú)
Åä·Ð 06-12 Á¦¶ó´½È¦ 09:55~10:05 Q&A ±èÀ¯ÂùÀÌ»óÁرèÁ¤ÀºÁ¤º¸¿µ±èÀçÈ«(¾ÆÁÖÀÇ´ë¾Æ¸§´Ù¿î³ª¶óÇǺΰúÇѾçÀÇ´ëÇѸ²ÀǴ뿬¼¼Á¶ÀºÇǺΰú)
±³À°½Ã°£ 06-12 Á¦¶ó´½È¦ 10:05~10:15 Identification of dermal melanin-containing cells in postinflammatory hyperpigmentation ȲÁ¤¹Î(¼¿ïÀÇ´ë)
±³À°½Ã°£ 06-12 Á¦¶ó´½È¦ 10:15~10:25 Age-dependent sequential increase of senescent cells in the skin ±èÅÂÇü(¾ÆÁÖÀÇ´ë)
ÈÞ½Ä 06-12 Á¦¶ó´½È¦ 10:25~10:55 Coffee Break ()
±³À°½Ã°£ 06-12 Á¦¶ó´½È¦ 10:55~11:10 Non-immunological factors in vitiligo pathogenesis ÃÖÁ¾¿ø(¼¿ïÀÇ´ë)
±³À°½Ã°£ 06-12 Á¦¶ó´½È¦ 11:10~11:25 Immunologic players involved in disease initiation and maintenance ÀÌÈñÁ¤(Â÷ÀÇ°ú´ëÇÐ)
Åä·Ð 06-12 Á¦¶ó´½È¦ 11:25~11:35 Q&A ¹ÚöÁ¾À̵¿À±ÃÖÁ¾¿øÀÌÈñÁ¤(°¡Å縯ÀǴ뼺±Õ°üÀǴ뼿ïÀÇ´ëÂ÷ÀÇ°ú´ëÇÐ)
±³À°½Ã°£ 06-12 Á¦¶ó´½È¦ 11:35~11:43 Genetic association between NALP1 polymorphism and non-segmental vitiligo in the Korean population ÀÌ»óµÎ(°æÈñÀÇ´ë)
±³À°½Ã°£ 06-12 Á¦¶ó´½È¦ 11:43~11:52 Association of adenotonsillar disease and adenotonsillectomy with the development of Vitiligo: A nationwide population-based cohort study in Korea ÀÌÀÏÀç(ÀüºÏÀÇ´ë)
±³À°½Ã°£ 06-12 Á¦¶ó´½È¦ 11:52~12:00 Effects of vitiligo serum-derived exosomes and stem cell-derived exosomes on autophagy, oxidative stress, and inflammation in human keratinocytes ±èÁøö(ÇѸ²ÀÇ´ë)
½Ä»ç 06-12 Á¦¶ó´½È¦ 12:00~13:40 Á¡½É½Ä»ç ()
±³À°½Ã°£ 06-12 Á¦¶ó´½È¦ 13:40~13:55 Treatment for stopping disease progression in active vitiligo: medication options and usages Á¤±âÇå(°æÈñÀÇ´ë)
±³À°½Ã°£ 06-12 Á¦¶ó´½È¦ 13:55~14:10 The ABC of phototherapy practice in vitiligo: Selection of NBUVB or excimer laser, initial and maximum dose, treatment duration for determination of treatment failure or others ±è´ë¼®(¿¬¼¼¿µÇǺΰú)
±³À°½Ã°£ 06-12 Á¦¶ó´½È¦ 14:10~14:25 Tips of skin grafting for vitiligo: ¡°Just do it¡± according to the lecture ¹èÁ¤¹Î(ÈúÇϿ콺ÇǺΰú)
Åä·Ð 06-12 Á¦¶ó´½È¦ 14:25~14:35 Q&A ±è±âÈ£±èÅÂÈï½ÅÁ¤ÇöÁ¤±âÇå±è´ë¼®¹èÁ¤¹Î(µ¿¾ÆÀÇ´ëÈÀÌÆ®¶óÀÎÇǺΰúÀÎÇÏÀÇ´ë°æÈñÀǴ뿬¼¼¿µÇǺΰúÈúÇϿ콺ÇǺΰú)
±³À°½Ã°£ 06-12 Á¦¶ó´½È¦ 14:35~14:43 New classification and treatment outcome of hand vitiligo: A cluster analysis ÁÖÇöÁ¤(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 06-12 Á¦¶ó´½È¦ 14:43~14:52 The efficacy of cyclosporine in progressive vitiligo Çѽ°æ(¿ìÅÂÇÏÇѽ°æÇǺΰú)
±³À°½Ã°£ 06-12 Á¦¶ó´½È¦ 14:52~15:00 Treatment results of tissue grafting in vitiligo: A single-center retrospective analysis ³ë¿ø¼®(¿¬¼¼ÀÇ´ë)
ÈÞ½Ä 06-12 Á¦¶ó´½È¦ 15:00~15:30 Coffee break and Poster viewing ()
±³À°½Ã°£ 06-12 Á¦¶ó´½È¦ 15:30~15:45 Partial unilateral lentiginosis, nevus spilus À¯ÈÁ¤(°í·ÁÀÇ´ë)
±³À°½Ã°£ 06-12 Á¦¶ó´½È¦ 15:45~16:00 Alternative treatment options for melasma refractory to laser toning ÃÖ¼ö¿µ(º¦¿¤ÇǺΰú)
±³À°½Ã°£ 06-12 Á¦¶ó´½È¦ 16:00~16:15 ´Ù¾çÇÑ ÀÓ»ó¾ç»ó¿¡¼ÀÇ ABNOM Ä¡·á ÀÓ»ó À̾߱⠹ÚÀÏÁß(´õÇǺΰú)
Åä·Ð 06-12 Á¦¶ó´½È¦ 16:15~16:30 Q&A ±è¹æ¼øÀ强ÀºÀÌÁ¾ÈñÀ¯ÈÁ¤ÃÖ¼ö¿µ¹ÚÀÏÁß(¿¡½º¿£À¯ÇǺΰú¿ï»êÀǴ뼺±Õ°üÀÇ´ë°í·ÁÀǴ뺦¿¤ÇǺΰú´õÇǺΰú)
±³À°½Ã°£ 06-12 Á¦¶ó´½È¦ 16:30~16:40 Treatment of partial unilateral lentiginosis using medium-fluence 1064 nm picosecond Nd-Yag Laser ¼º¼³È(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 06-12 Á¦¶ó´½È¦ 16:40~16:50 The efficacy and safety of low-fluence 1064nm picosecond Nd-Yag laser compared with low-fluence photoacoustic therapy pulsed mode 1064nm Q-switched Nd-Yag laser for treatment of melasma: A prospective split-face study À̼ҿ¬(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 06-12 Á¦¶ó´½È¦ 16:50~17:00 Clinical benefit of moisturizer for improvement of post-inflammatory hyperpigmentation in atopic dermatitis lesion: A comparative study with the combination of topical tacrolimus Á¤¿¬ÁÖ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 06-12 Á¦¶ó´½È¦ 17:00~17:10 Split-face comparative study of 785-nm picosecond Nd-Yag laser and precision cryotherapy combination treatment for facial benign pigmented lesions °í¿µ±Ô(Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 06-12 Á¦¶ó´½È¦ 17:10~17:50 Vitiligo: From pathogenesis, with a focus on the innate immunity, to therapeutic perspectives Thierry Passeron(Department of Dermatology Université Côte d¡¯Azur in Nice France)